These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9933673)

  • 41. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
    Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
    AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
    Bolondi L; Gaiani S; Celli N; Golfieri R; Grigioni WF; Leoni S; Venturi AM; Piscaglia F
    Hepatology; 2005 Jul; 42(1):27-34. PubMed ID: 15954118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma.
    Krinsky GA; Lee VS; Nguyen MT; Rofsky NM; Theise ND; Morgan GR; Teperman LW; Weinreb JC
    Radiology; 2001 Jan; 218(1):47-53. PubMed ID: 11152778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal masses in cirrhotic liver: CT and MR imaging features.
    Taylor AJ; Carmody TJ; Quiroz FA; Erickson SJ; Varma RR; Komorowski RA; Foley WD
    AJR Am J Roentgenol; 1994 Oct; 163(4):857-62. PubMed ID: 8092023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality.
    Kondo F; Ebara M; Sugiura N; Wada K; Kita K; Hirooka N; Nagato Y; Kondo Y; Ohto M; Okuda K
    Hepatology; 1990 Sep; 12(3 Pt 1):592-8. PubMed ID: 1698171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
    Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
    J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.
    Shinmura R; Matsui O; Kobayashi S; Terayama N; Sanada J; Ueda K; Gabata T; Kadoya M; Miyayama S
    Radiology; 2005 Nov; 237(2):512-9. PubMed ID: 16244260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.
    Lim JH; Choi D; Cho SK; Kim SH; Lee WJ; Lim HK; Park CK; Paik SW; Kim YI
    Radiology; 2001 Sep; 220(3):669-76. PubMed ID: 11526265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ; Byun JH; Kim JY; Hong GS; Won HJ; Shin YM; Kim PN
    Abdom Imaging; 2015 Jan; 40(1):64-75. PubMed ID: 24997560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.
    Wang F; Jing X; Wang T; Li G; Li T; Zhang Q; Huang Y; Li J; Wang Y; Gao Y; Han T; Du Z
    Am J Clin Pathol; 2012 Jun; 137(6):937-45. PubMed ID: 22586053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.
    Lencioni R; Mascalchi M; Caramella D; Bartolozzi C
    Abdom Imaging; 1996; 21(1):41-8. PubMed ID: 8672971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
    Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
    AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
    Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
    Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging of small hepatocellular carcinoma.
    Hirai K; Aoki Y; Majima Y; Abe H; Nakashima O; Kojiro M; Tanikawa K
    Am J Gastroenterol; 1991 Feb; 86(2):205-9. PubMed ID: 1846998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications.
    Jeong YY; Mitchell DG; Kamishima T
    AJR Am J Roentgenol; 2002 Jun; 178(6):1327-34. PubMed ID: 12034592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
    Choi D; Mitchell DG; Verma SK; Bergin D; Navarro VJ; Malliah AB; McGowan C; Hann HW; Herrine SK
    Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.